Randomized Trial of Dapagliflozin in Patients With Nondiabetic Stage 4 CKD

Dapagliflozin safely ameliorates (compensatory) glomerular hyperfiltration and proteinuria and is glycosuric in nondiabetic patients with preterminal CKD. GFR reduction is likely because of postglomerular vasodilation rather than preglomerular vasoconstriction.

Authors

Institutions

Publication Details

Journal
Kidney International Reports
Published
2025-07-24
DOI
https://doi.org/10.1016/j.ekir.2025.07.020
Citations
1
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
1.29
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Randomized Trial of Dapagliflozin in Patients With Nondiabetic Stage 4 CKD

Matias Trillini, Sandro Sironi, Paola Boccardo, Nadia Rubis et al.
1 citations
Kidney International Reports
Diabetes Treatment and Management
1.29
article

Randomized Trial of Dapagliflozin in Patients With Nondiabetic Stage 4 CKD

Matias Trillini, Sandro Sironi, Paola Boccardo, Nadia Rubis, Anna Caroli, Alessandro Villa, Francesco Peraro, Giovanni Giuliano, Dominique Cadé, Sara Gamba, Andrea Remuzzi, SL Borchetto, Giulia Gherardi, Silvia Prandini, Elena Perticucci, F Gregis, Fabiola Carrara, Erica Daina, Daniela Cugini, Antonio Nicola Cannata, Flavio Gaspari, Annalisa Perna, S. Peracchi, Erika Diani, Alessia Gennarini, Nadia Stucchi, Paolo Brambilla, Rosa Caruso, Tiziano Gamba, Davide Martinetti, Vincenzo Gambara, Norberto Perico, Elena Bresin, V. Lecchi, Tobia Peracchi, B Taddei, Diego Fidone, Silvia Ferrari, Giulia Villa, Davide Villa, Piero Ruggenenti, Stefano Rota, Valentina Leone, Antonio Chiappa, Chiara Guarinoni, Francesca Abbadini, Jennifer Piffari
article en
1 citations

Abstract

Dapagliflozin safely ameliorates (compensatory) glomerular hyperfiltration and proteinuria and is glycosuric in nondiabetic patients with preterminal CKD. GFR reduction is likely because of postglomerular vasodilation rather than preglomerular vasoconstriction.

Kidney International ReportsVol. 10(10)
Mario Negri Institute for Pharmacological Research (IT), Ospedale Papa Giovanni XXIII (IT)
Good health and well-being
Openalex Percentile: Top 17%
Diabetes Treatment and Management
1.29
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.